Ligand Pharmaceuticals

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Ligand Pharmaceuticals 是一家在股票代码 LGND (US) 下上市的公司。

他们在：

• 药店67%
• 生物技术33%

查看带有其 28 名主要高管的组织结构图

Ligand Pharmaceuticals 搜索最多的简介

• Todd Davis, Director and Chief Executive Officer
• John LaMattina, Director
• Jason Aryeh, Director

高管在Ligand Pharmaceuticals变化

• Matthew Korenberg, President and Chief Operating Officer 请很快离开公司  (新闻发布的2024八月5号).

创建提醒
跟踪 Ligand Pharmaceuticals 的高管变动

Ligand Pharmaceuticals 拥有 1,833 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。

Popular M&A news in 药店

• Knight Therapeutics has announced the acquisition of Paladin Labs  (公布2025三月12号).
• Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
• Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma  (公布2025二月25号).

药店 行业的其他推荐联系人

• Adare Pharmaceuticals 企业 Kristin Berkinsky - Chief Human Resources Officer
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board
• Braeburn Pharmaceuticals 企业 Seth Harrison - Chairman and Director

了解更多有关药店行业的信息 >

Ligand Pharmaceuticals 的最新新闻稿

• Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
• Ligand to Participate in March Investor Conferences
• Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
• Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
• Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
• Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
• Ligand to Present at Stifel 2024 Healthcare Conference
• Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
• Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
• Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
• View more press releases Close

关于 Ligand Pharmaceuticals 的社交媒体

• Ligand Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
• Ligand Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube